Index for
slide deck
Course, natural history and prognosis

Course, natural history and prognosis
The course of Parkinson’s disease

The course of Parkinson’s disease

The progression of Parkinson’s disease
The clinical effects of Parkinson’s disease (PD) are often visually obvious, but the underlying pathology of PD is still not fully understood.1,2 PD pathology is thought to spread from brain region to brain region over multiple long-distance relays during long periods of …

Clinical symptoms and time course of Parkinson’s disease progression
The progression of PD is generally slow, taking place over years (often many years).4 While diagnosis tends to occur with the onset of motor symptoms, this can be preceded by a long prodromal phase of 15 years or more.5 This prodromal phase is typically characterised by a…

The effect of genetic subtypes of Parkinson’s disease on disease course
Compared with people with sporadic Parkinson’s disease, people with LRRK2-associated Parkinson’s disease tend to experience few cognitive and psychiatric symptoms, with slower disease progression, whereas people with GBA-associated Parkinson’s disease tend to experience a…

Thresholds for the appearance of Parkinson’s disease symptoms
During Stage 1 of PD, many individuals experience a loss of smell (hyposmia) and/or suffer from constipation.2 In addition, sleep may become disordered or disturbed, accompanied by crying out, punching, or kicking during rapid eye movement (REM) sleep,2,3 and people may e…

The therapeutic benefits of modifying the disease course
While there have been major advances in the management and reduction of PD-related symptoms, there is still no effective way of preventing or slowing the underlying neurodegeneration.2,5 As the disease becomes more extensive during its advanced stages, the ability of drug…

Change in levodopa response over time – ‘wearing-off’
Levodopa is the major symptomatic therapy for PD and is the most common first-line therapy because it provides benefit to virtually all patients.1,3 In the short-term, the effects of levodopa tend to be long-lasting and side effects are tolerable.1 In the longer-term, how…

Definitions of terms used in Parkinson’s disease
The slide includes some basic definitions of terms used to describe the course of PD.
References used on slide:
1.Kalia LV, Lang AE. Parkinson’s disease. Lancet 2015; 386 (9996): 896–912.
2.Stacy M, Bowron A, Guttman M, et al. Identification of motor and nonmotor wearin…

Drug-induced dyskinesias in Parkinson’s disease
Levodopa-induced dyskinesias cover a broad clinical spectrum of different types of involuntary movements, ranging from chorea affecting the limbs, trunk, and head, slow dystonic movements, fixed dystonic postures, or (more rarely) myoclonus or ballism.1,2 Levodopa-induced…

Relationship between levodopa administration and motor fluctuations
As the extent of neurodegeneration in the substantia nigra becomes greater, its capacity to produce dopamine diminishes to the point where patients require larger doses of levodopa to maintain normal function.4 Motor complications, such dyskinesia and motor fluctuations, …